Related references
Note: Only part of the references are listed.Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
G. von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma
Anne-Sophie Hamy et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Risk Factors for Locoregional Disease Recurrence After Breast-Conserving Therapy in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy: An International Collaboration and Individual Patient Meta-Analysis
Antonios Valachis et al.
CANCER (2018)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer
Victor E. Chen et al.
ADVANCES IN RADIATION ONCOLOGY (2017)
Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy
Shannon K. Swisher et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V
Marco Colleoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation
T. Jonathan Yang et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Regional Nodal Irradiation in Early-Stage Breast Cancer
Timothy J. Whelan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
P. M. Poortmans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial
H. Bonnefoi et al.
ANNALS OF ONCOLOGY (2014)
Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancer
Moon Ki Choi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Locoregional recurrence (LRR) after neoadjuvant chemotherapy (NAC): Pooled-analysis results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC).
Eleftherios P. Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
P. McGale et al.
LANCET (2014)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Predictors of locoregional outcome in patients receiving neoadjuvant therapy and postmastectomy radiation
Jean L. Wright et al.
CANCER (2013)
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27
Eleftherios P. Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy
Laura S. Dominici et al.
BREAST CANCER RESEARCH (2012)
Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy
Abigail S. Caudle et al.
BREAST CANCER RESEARCH (2012)
Impact of Breast Cancer Molecular Subtypes on Locoregional Recurrence in Patients Treated with Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
Michael O. Meyers et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century
Olivia Pagani et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer
Mitch Dowsett et al.
CLINICAL CANCER RESEARCH (2008)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome
Chafika Mazouni et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors
V Guarneri et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial
J Ragaz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: Results from five national surgical adjuvant breast and bowel project randomized clinical trials
A Taghian et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Risk factors for locoregional recurrence among breast cancer patients:: Results from international breast cancer study group trials I through VII
A Wallgren et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
IF Faneyte et al.
BRITISH JOURNAL OF CANCER (2003)
Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation
A Katz et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
